Catholic healthcare should establish comprehensive compliance strategies, beyond following Medicare reimbursement laws, that reflect mission and ethics. A covenant model of business ethics--rather than a self-interest emphasis on contracts--can help organizations develop a creed to focus on obligations and trust in their relationships. The corporate integrity program (CIP) of Mercy Health System Oklahoma promotes its mission and interests, educates and motivates its employees, provides assurance of systemwide commitment, and enforces CIP policies and procedures.
In 2000, Bon Secours Health System began a growth spurt that added eight hospitals, spreading its operations across nine states. But now it's a different story; since last November the system has announced plans or deals to sell facilities in Florida and Virginia, and leave New Jersey entirely. Incoming CEO Richard Statuto, left, faces a handful of challenges. "We need to determine how effective they've been at right-sizing their organization," a Standard & Poor's analyst says.
Who are these healthcare whistleblowers, and what motivates them? Some observers say it's a resolve to do the right thing when no one else will act, while others say greed and revenge are the driving forces. We profile three whistleblowers and show how their actions have affected their lives and the healthcare industry.
Discriminating altruism, particularly kin altruism, is a fundamental mechanism of cooperation in nature. Altruistic behavior is not favored by evolution in the circumstances where there are "kin cheaters" that cannot be effectively identified. Using evolutionary iterated prisoner's dilemma, we deduce the condition for discriminating strategies to be evolutionarily stable and show that the competition between groups of different discriminating strategies restrains the percentage of kin cheaters.
OBJECTIVE: To assess the prevalence of counterfeit antimalarial drugs in Southeast (SE) Asia. DESIGN: Cross-sectional survey. SETTING: Pharmacies and shops selling antimalarial drugs in Myanmar (Burma), Lao PDR, Vietnam, Cambodia and Thailand. MAIN OUTCOME MEASURES: Proportion of artemisinin derivatives or mefloquine containing drugs of substandard quality. RESULTS: Of the 188 tablet packs purchased which were labelled as 'artesunate' 53% did not contain any artesunate.
BACKGROUND: Since 1998 the serious public health problem in South East Asia of counterfeit artesunate, containing no or subtherapeutic amounts of the active antimalarial ingredient, has led to deaths from untreated malaria, reduced confidence in this vital drug, large economic losses for the legitimate manufacturers, and concerns that artemisinin resistance might be engendered.
The U.S. Congress determined quackery to be the most harmful consumer fraud against elderly people. Americans waste $27 billion annually on questionable health care, exceeding the amount spent on biomedical research. Quackery is characterized by the promotion of false and unproven health schemes for profit and does not necessarily involve imposture, fraud, or greed. The real issues in the war against quackery are the principles, including scientific rationale, encoded into consumer protection laws, primarily the U.S. Food, Drug, and Cosmetic Act. More such laws are badly needed.
In 1998, a Lancet paper described 12 cases of children with autism, and having been vaccinated (MMR) in the United Kingdom; medias presented the information to the lay public, stating that a link was possible. In 2004, The Lancet published letters responding to allegations against the paper. Later, it was established that no link existed between MMR and autism; few years and many publications were necessary to conclude to the absence of evidence.